Earlier this week, I discussed how healthcare and life science companies need to jump the curve to the idea of a $1000 genome. I have also written about how advances in genomics will transform business (here, here and here), but in the latest development Amazon recently announced it would begin allowing businesses (and individuals) to access its massive genome database. It is yet another reason why the era of personalized medicine is accelerating.
